Released on = April 30, 2007, 3:44 am

Press Release Author = Shushmul Maheshwari

Industry = Biotech

Press Release Summary = The dynamically growing US biotech market can emerge as an
outsourcing hub. Malaysia, to make its mark on the global biotech market, is looking
to attract biotech exports from US.

Press Release Body = Malaysia, in May 2007 at the BIO International Convention (BIO
2007), will look to pull biotechnology exports, particularly from US, to the nation.

The Biotechnology Industry Organisation (BIO) will organize the BIO 2007 scheduled
to be held in Boston, Massachusetts, from May 6 to May 9, 2007.

Presently, BIO is a representative body for approx 1,100 biotech companies, state
biotech centers, academic institutions, and other related organizations in all US
states and 31 other countries.

Datuk Seri Dr Jamaludin Jarjis, Science, Technology and Innovation Minister,
Malaysia, told on April 20, 2007 that his country would see this event as a global
stage to attract the attention of the potential investors in the nation as a
favorable export destination, as reported by BERNAMA.COM.

He further said at a press conference on the participation of Malaysia at BIO 2007,
“There is flourishing interest from the West on outsourcing of the
biotechnology sector to Asia. Malaysia is strategically located in Asia and we
should make use of the interest to woo those involved to our country”.

BIO members have their involvement in diverse fields, like agriculture,
environmental, industrial, and healthcare biotech products.

Deputy Prime Minister Datuk Seri Mohd Najib Tun Abdul Razak will lead the Malaysian
delegation of 300 representatives at BIO 2007. The number of delegates has increased
enormously this year as compared to 150 in previous year and 100 in 2005.

According to the RNCOS report “US Biotech Market Analysis”, US
biotechnology market has had a share of over 50% in the global biotech market in
2005. It grew at a CAGR of 15.16% during the period 2001 to 2005 and is projected to
exceed US$ 131 Billion by 2010 rising at a CAGR of about 15.5%. This volcanic growth
is expected to open new vistas for the US biotech market in diverse fields of
biotechnology.

The market research report provides a comprehensive overview on the US biotech
industry. The report is a collection of facts and forecasts on the distinct
segments, like bio medical, agriculture, clinical trials, etc, that make up the
framework of US biotech industry. It throws light on the various parameters that
define the biotech industry in US, like current biotech business models, production
and economic impacts, clinical trials, M&As, R&D, and strategic alliances. Key
drivers, opportunities, challenges, and future outlook have been analyzed prudently
for investors.

About RNCOS E-Services Pvt Ltd.:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today\'s globally competitive environment.

For more information visit: http://www.rncos.com/Report/IM0300.htm
Current Industry News: http://www.rncos.com/blog


Web Site = http://www.rncos.com

Contact Details = RNCOS E-Services Pvt Ltd.
Shushmul Maheshwari
Head of Business Development
29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229
info@rncos.com